Naglla A. Elimam

Jeddah, 21423, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study.

Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study.

Journal: Pharmacy (Basel, Switzerland)

Published: April 15, 2025

Value of routine blood count surveillance in detecting relapse in acute lymphoblastic leukemia.

Value of routine blood count surveillance in detecting relapse in acute lymphoblastic leukemia.

Journal: Frontiers in pediatrics

Published: August 30, 2024

Unraveling the Prognostic Role of t(1:19) in Pediatric Pre-B Acute Lymphoblastic Leukemia: Insights from a Saudi Nationwide Cohort.

Unraveling the Prognostic Role of t(1:19) in Pediatric Pre-B Acute Lymphoblastic Leukemia: Insights from a Saudi Nationwide Cohort.

Journal: Cancer genetics

Published: June 09, 2024

Vitamin D Deficiency in Pediatric Oncology Patients: A Single-Center Experience in Saudi Arabia.

Vitamin D Deficiency in Pediatric Oncology Patients: A Single-Center Experience in Saudi Arabia.

Journal: Cureus

Published: February 22, 2024

The Characteristics and Follow-Up of SARS-CoV-2 Infection in Pediatric Oncology Patients.

The Characteristics and Follow-Up of SARS-CoV-2 Infection in Pediatric Oncology Patients.

Journal: Cureus

Published: September 27, 2023

Renal outcomes in pediatric patients with sickle cell disease: a single center experience in Saudi Arabia.

Renal outcomes in pediatric patients with sickle cell disease: a single center experience in Saudi Arabia.

Journal: Frontiers in pediatrics

Published: September 17, 2023

Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immunoglobulin production.

Outcomes of blinatumomab based therapy in children with relapsed, persistent, or refractory acute lymphoblastic leukemia: a multicenter study focusing on predictors of response and post-treatment immunoglobulin production.

Journal: Pediatric hematology and oncology

Published: October 06, 2022

Metastatic 4S neuroblastoma with excellent outcome in Saudi cancer center.

Metastatic 4S neuroblastoma with excellent outcome in Saudi cancer center.

Journal: Saudi medical journal

Published: August 20, 2021

A clinical approach to non-neutropenic fever in children with cancer.

A clinical approach to non-neutropenic fever in children with cancer.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: June 02, 2020

Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.

Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: March 20, 2019

FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.

FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: December 07, 2018

Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia.

Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia.

Journal: Experimental hematology & oncology

Published: September 09, 2018

Showing 1-12 of 18

Last Updated: 09/26/2026